RBR-66jx7j
Active, not recruiting
未知
Metabolic, inflammatory, genetic and satiety response to consumption of monounsaturated fatty acids and fructose
niversidade Federal de Viçosa0 sitesDecember 26, 2016
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversidade Federal de Viçosa
- Status
- Active, not recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Healthy volunteers; female; non\-smoker; aged 20\-40 years; normal weight (BMI between 18\.5\-24\.9 kg / m 2\) or overweight / obesity class I (BMI 25\.0 to 35\.0 kg / m2\); stable weight in the last three months (less than 5% of usual weight).
Exclusion Criteria
- •Pregnancy; lactiontion; or menopause; infections or inflammation in the experiment days; inflammatory, heart, liver, renal, gastrointestinal and respiratory diseases; hormonal treatment or prescribed drug that affect the digestion and absorption of nutrients; in use of hormones or drugs that affect energy, glucose or lipid metabolism; smoker; history of abuse of alcohol or drugs; unstable weight in the last three months (higher than 5% of usual weight); athlete.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Assessment of Metabolic and pathological Response to Treatment with Radio-chemotherapy (RCT) and Immunotherapy (ImT) before Surgery in locally advanced Esophageal and gastro-esophageal junction cancer: ARTemIS-Eso, a three-level, open-label, phase I-II studyAdenocarcinomas of the esophagus or gastro-esophageal junction and squamous cell carcinoma of the esophagus.MedDRA version: 20.0 Level: PT Classification code 10061534 Term: Oesophageal squamous cell carcinoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10030137 Term: Oesophageal adenocarcinoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2016-000935-42-BEInstitut Jules Bordet100
Not yet recruiting
Not Applicable
The study on metabolic and inflammatory biomarkers and gut microbiota in overweight Thai adultsto investigate and compare the metabolic, inflammatory biomarkers and gut microbiota composition of normal and overweight in a nationally representative sample of Thai adults. Then, associations between will be analysed gut microbial concentrations, clinical-biochemical blood parameters and dietary patterns will be assessed.Overweight, metabolic biomarkers, inflammatory biomarkers, gut microbiota, dietary patternTCTR20220204007Fundamental fund Kasetsart University60
Completed
Not Applicable
Metabolism, Nutrition, and the Immune System - a study in the Augsburg region (MEIA)Metabolic diseasessusceptibility to infectionDRKS00028738ehrstuhl für Epidemiologie, Universität Augsburg, Universitätsklinikum Augsburg; IBE, Ludwig-Maximilians-Universität München598
Recruiting
Not Applicable
Metabolic, neuronal and immunological regulation of body weightParticipants within all BMI-categories ( underweight up to obesity grade III) are eligible for participation in this basic research study.DRKS00027068niversität zu Köln, Poliklinik für Endokrinologie, Diabetologie und Präventivmedizin800
Completed
Not Applicable
The nutritional, cardiovascular and immunological effect of daily subcutaneous ghrelin in dialysis patients with evidence of malnutritioMalnutrition or renal failureNutritional, Metabolic, EndocrineMalnutrition, kidney failureISRCTN43319045Hammersmith Hospitals NHS Trust (UK)20